Kinsella Group Names Two New Managing Directors

Kinsella Group is happy to announce that Curt Jennewine and Dan Greene have been named Managing Directors of the Firm. Both are fully licensed FINRA Broker Dealer Representatives. Congratulations to Curt and Dan.

Curt has successfully represented OEM and contract manufacturing clients of the Firm in acquisition search and sale assignments in the US and Japan. His knowledge of the medical device industry to include orthobiologics is deep and broad. Please do reach out to Curt for sale and buy side needs. Curt.Jennewine@Kinsellagroup.com

Dan Greene has represented acquisition search clients of the Firm in the medtech contract manufacturing sector and is working with companies who not only have a medtech interests but also an aerospace focus. Please do reach out to Dan for contract manufacturing buy side needs. Daniel.Greene@Kinsellagroup.com .

Note also that Kinsella Group is at Medica in Dusseldorf this week after having been at Softcot (French orthopedic industry meeting) in Paris last week. Most recently at Biomed Boston and MD&M Minneapolis and soon to be at BioMed San Jose. The Firm will have served clients by attendance at over 12 trade shows and meetings in the US and Europe in 2022.

Kinsella Group, Inc is an investment bank focused exclusively on the MedTech and medical contract manufacturing markets. Kinsella Group has been representing buyers and sellers in this space for over 20 years, working to exceed desired outcomes. For more information, please contact Bob Kinsella at robert.kinsella@kinsellagroup.com or by calling (312)229-1357.